Author： Zak Krzysztof Pecak Aleksandra Rys Barbara Wladyka Benedykt Dömling Alexander Weber Lutz Holak Tad A Dubin Grzegorz
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.4, 2013-04, pp. : 425-448
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Recent Advances of p53-MDM2 Small Molecule Inhibitors (2011-Present)
Current Medicinal Chemistry, Vol. 22, Iss. 5, 2015-02 ,pp. :
MDM2 Inhibitors for Pancreatic Cancer Therapy
Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 6, 2010-06 ,pp. :
Targeting MDM2 and MDMX in Retinoblastoma
Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. :
Current Pharmaceutical Design, Vol. 18, Iss. 30, 2012-10 ,pp. :